AU2018217352A1 - Improved method for epigenetic immune cell counting - Google Patents

Improved method for epigenetic immune cell counting Download PDF

Info

Publication number
AU2018217352A1
AU2018217352A1 AU2018217352A AU2018217352A AU2018217352A1 AU 2018217352 A1 AU2018217352 A1 AU 2018217352A1 AU 2018217352 A AU2018217352 A AU 2018217352A AU 2018217352 A AU2018217352 A AU 2018217352A AU 2018217352 A1 AU2018217352 A1 AU 2018217352A1
Authority
AU
Australia
Prior art keywords
blood
cells
cell
nucleic acid
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018217352A
Other languages
English (en)
Inventor
Sven Olek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precision for Medicine GmbH
Original Assignee
Prec For Medicine GmbH
Precision for Medicine GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec For Medicine GmbH, Precision for Medicine GmbH filed Critical Prec For Medicine GmbH
Publication of AU2018217352A1 publication Critical patent/AU2018217352A1/en
Assigned to PRECISION FOR MEDICINE GMBH reassignment PRECISION FOR MEDICINE GMBH Amend patent request/document other than specification (104) Assignors: EPIONTIS GMBH
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2018217352A 2017-02-09 2018-02-08 Improved method for epigenetic immune cell counting Abandoned AU2018217352A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17155496.7 2017-02-09
EP17155496.7A EP3360971A1 (en) 2017-02-09 2017-02-09 Improved method for epigenetic immune cell counting
PCT/EP2018/053206 WO2018146209A1 (en) 2017-02-09 2018-02-08 Improved method for epigenetic immune cell counting

Publications (1)

Publication Number Publication Date
AU2018217352A1 true AU2018217352A1 (en) 2019-08-08

Family

ID=58016595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018217352A Abandoned AU2018217352A1 (en) 2017-02-09 2018-02-08 Improved method for epigenetic immune cell counting

Country Status (7)

Country Link
US (1) US11319581B2 (https=)
EP (2) EP3360971A1 (https=)
JP (1) JP2020505938A (https=)
CN (1) CN110382713A (https=)
AU (1) AU2018217352A1 (https=)
CA (1) CA3051314A1 (https=)
WO (1) WO2018146209A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018116353B4 (de) * 2018-07-05 2020-06-10 Epiontis Gmbh Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening
WO2024073508A2 (en) * 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
CN119372296B (zh) * 2024-12-24 2025-06-13 北京致谱医学检验实验室有限公司 基于基因甲基化检测实现人b淋巴细胞计数的试剂盒
CN119372341B (zh) * 2024-12-30 2025-04-11 北京致谱医学检验实验室有限公司 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130021400A (ko) * 2005-04-15 2013-03-05 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
DK2199411T3 (en) * 2008-12-16 2015-08-03 Epiontis Gmbh Epigenetic markers for the identification of CD3-positive T lymphocytes
WO2013135454A1 (en) * 2012-03-12 2013-09-19 Epiontis Gmbh Epigenetic marker for the identification of cd3cd4 positive t lymphocytes
CN103031372A (zh) * 2012-08-10 2013-04-10 深圳先进技术研究院 Znf545基因甲基化定量检测方法
GB201221133D0 (en) * 2012-11-23 2013-01-09 Epiontis Gmbh Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes
JP6590790B2 (ja) * 2013-04-19 2019-10-16 エピオンティス ゲーエムベーハー 生体サンプルにおける定量的細胞組成を特定する方法

Also Published As

Publication number Publication date
WO2018146209A1 (en) 2018-08-16
CA3051314A1 (en) 2018-08-16
CN110382713A (zh) 2019-10-25
US20190390263A1 (en) 2019-12-26
US11319581B2 (en) 2022-05-03
EP3360971A1 (en) 2018-08-15
EP3580358A1 (en) 2019-12-18
JP2020505938A (ja) 2020-02-27

Similar Documents

Publication Publication Date Title
Baron et al. Epigenetic immune cell counting in human blood samples for immunodiagnostics
Angulo et al. A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry
US11319581B2 (en) Method for epigenetic immune cell counting
Guo et al. Detection of plasma EGFR mutations in NSCLC patients with a validated ddPCR lung cfDNA assay
US11186878B2 (en) Method for predicting and monitoring response to an immune checkpoint inhibitor
Herreros-Villanueva et al. KRAS mutations: analytical considerations
Liu et al. Laboratory-developed droplet digital PCR assay for quantification of the JAK2V617F mutation
US12006546B2 (en) Method for epigenetic immune cell detection and counting in human blood samples
McCafferty et al. A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
KR102036222B1 (ko) 당뇨병성 신증에 의한 만성신장질환 환자의 예후 예측용 마커
HK1259669A1 (en) Improved method for epigenetic immune cell counting
EP3818179B1 (en) Epigenetic method to detect and distinguish ipex and ipex-like syndromes, in particular in newborns
EP4269614A1 (en) Method for detecting copy number of specific nucleic acid per single cell
Zheng et al. Quantification of JAK2V617F mutation load by droplet digital PCR can aid in diagnosis of myeloproliferative neoplasms
Li et al. The 1357 bp deletion in β-thalassemia: molecular profiling and hematological characterization in a Guangxi cohort
CN119372341B (zh) 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒
CN119242823B (zh) 基于基因甲基化检测实现人t淋巴细胞计数的试剂盒
KR102036220B1 (ko) 만성신장질환 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법
KR102036219B1 (ko) 유전자 프로모터의 CpG 메틸화 변화를 이용한 만성신장질환의 악화 예측용 조성물 및 이의 이용
Douzandegan et al. Development of a LAMP-based diagnostic method for HTLV-1 using Iranian clinical samples
KR102036221B1 (ko) 만성신장질환의 예후 예측을 위한 후성 유전학적 진단 키트 개발
Cai et al. P731: TERT gene promoter region mutation analysis in glioma using multiplex SNaPshot method
Kawser et al. SARS-CoV-2 variant survey: Comparison of RT-PCR screening with TGS and variant distribution across two divisions of Bangladesh
Romanov et al. A noninvasive assay for monitoring renal allograft status
Maguire et al. Focussing on genomic and phenomic correlations in respiration of non-melanotic skin cancers

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: PRECISION FOR MEDICINE GMBH

Free format text: FORMER NAME(S): EPIONTIS GMBH

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application